Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
21.22
-0.32 (-1.49%)
At close: May 22, 2026, 4:00 PM EDT
21.87
+0.65 (3.04%)
After-hours: May 22, 2026, 7:00 PM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $743.82 million as of May 22, 2026. Its market cap has increased by 1,154.59% in one year.
Market Cap
743.82M
Enterprise Value
501.97M
1-Year Change
1,154.59%
Ranking
Category
Stock Price
$21.22
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $743.82M, an increase of 40.69%. That is a compound annual growth rate of 15.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 743.82M | 34.51% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 806.39M |
| Avalo Therapeutics | 802.07M |
| Absci | 795.12M |
| ARS Pharmaceuticals | 788.47M |
| Vor Biopharma | 776.48M |
| Relmada Therapeutics | 738.41M |
| Tenax Therapeutics | 714.19M |
| SpyGlass Pharma | 696.61M |